Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UBL7-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
RBM33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KLHL23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BIRC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTN3A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HACD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNPY3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC102723773 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP57L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBRG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC136 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VTI1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VAPB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RGS14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
METTL2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FASTK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TERF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AHCY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IMPA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on